CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
Clin Mol Hepatol. 2021;27(3):402-412.   Published online 2021 June 23    DOI: https://doi.org/10.3350/cmh.2021.0179

Excel Download

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Clinical and Molecular Hepatology. 2021;27(3):402-412   Crossref logo
Link1 Link2 Link3

Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naïve Chronic Hepatitis B Patients in Korea
Journal of Korean Medical Science. 2021;36(14):   Crossref logo
Link1 Link2 Link3

Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
Liver Cancer. 2021;1-2   Crossref logo
Link1 Link2

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
Alimentary Pharmacology & Therapeutics. 2019;51(2):314-315   Crossref logo
Link1 Link2

Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?
Gastroenterology. 2020;158(8):2311-2312   Crossref logo
Link1 Link2

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply
Alimentary Pharmacology & Therapeutics. 2019;51(2):315-316   Crossref logo
Link1 Link2

Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B – Authors' reply
The Lancet Gastroenterology & Hepatology. 2021;6(2):87-88   Crossref logo
Link1 Link2

Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Gastroenterology. 2020;158(8):2310-2311   Crossref logo
Link1 Link2

Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Hepatology Research. 2018;48(11):862-871   Crossref logo
Link1 Link2

739 ENTECAVIR VS. TENOFOVIR IN PREVENTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS
Gastroenterology. 2020;158(6):S-1289   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.